Erscheint: Oktober 2026
Buch (Hardcover): Fachbuch
Current Topics in Nonclinical Drug Development
Volume 3
Verlag:
Taylor & Francis Unsere-Artikel-Nr.: P36174096
EAN: 9781032803500
Erscheint: Oktober 2026
Versand: Kostenlos
-23.1 %
CHF 295.–
CHF 227.–
Beschreibung
This third volume in the series focuses on such germane issues as the weight of evidence approach, applying the 3Rs (replacement, reduction, and refinement), personalized drug therapies, and oncology therapeutics, among others. Volumes in this series are aimed at toxicologists and toxicologic pathologists involved in drug development. Volumes in the Current Topics in Nonclinical Drug Development series are aimed at toxicologists, toxicologic pathologists, regulators, and study directors dealing with issues in study design, evaluation of findings, and presentation of data. In addition, the series will serve as an aid to academicians and graduate students studying nonclinical drug development. Key Features:. Explores the critical issues and current topics important in nonclinical drug development. Deals with day-to-day issues in study design, evaluation of findings, and presentation of data. Aids academicians and graduate students pursuing research related to nonclinical drug development. Delves into both the art and science of nonclinical drug development and its impact on translational medicine and human safety.
Spezifikationen
Sprache
- Englisch
Autor
- Sahota Pritam S.
- Bentley Philip
- Zbigniew W. Wojcinski
Zielgruppe
- Professional Reference
Erscheinungsjahr
- 2026
Format
- Buch (Hardcover)
Anzahl Seiten
- 328